BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15145218)

  • 1. Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model.
    Mahmud N; Pang W; Cobbs C; Alur P; Borneman J; Dodds R; Archambault M; Devine S; Turian J; Bartholomew A; Vanguri P; Mackay A; Young R; Hoffman R
    Exp Hematol; 2004 May; 32(5):494-501. PubMed ID: 15145218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
    Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.
    Masuda S; Ageyama N; Shibata H; Obara Y; Ikeda T; Takeuchi K; Ueda Y; Ozawa K; Hanazono Y
    Exp Hematol; 2009 Oct; 37(10):1250-1257.e1. PubMed ID: 19638293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
    Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage.
    François S; Bensidhoum M; Mouiseddine M; Mazurier C; Allenet B; Semont A; Frick J; Saché A; Bouchet S; Thierry D; Gourmelon P; Gorin NC; Chapel A
    Stem Cells; 2006 Apr; 24(4):1020-9. PubMed ID: 16339642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
    Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC
    Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2004 Nov; 32(11):1110-7. PubMed ID: 15539090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: Engraftment, donor cell distribution, and mechanistic basis.
    Feng Q; Chow PK; Frassoni F; Phua CM; Tan PK; Prasath A; Khee Hwang WY
    Exp Hematol; 2008 Nov; 36(11):1556-66. PubMed ID: 18722042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells.
    Barese C; Pech N; Dirscherl S; Meyers JL; Sinn AL; Yoder MC; Goebel WS; Dinauer MC
    Stem Cells; 2007 Jun; 25(6):1578-85. PubMed ID: 17347493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice.
    Zhang J; Gong JF; Zhang W; Zhu WM; Li JS
    J Biomed Sci; 2008 Sep; 15(5):585-94. PubMed ID: 18763056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
    Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S
    Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
    Sbano P; Cuccia A; Mazzanti B; Urbani S; Giusti B; Lapini I; Rossi L; Abbate R; Marseglia G; Nannetti G; Torricelli F; Miracco C; Bosi A; Fimiani M; Saccardi R
    Arch Dermatol Res; 2008 Mar; 300(3):115-24. PubMed ID: 18259766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.
    Freyman T; Polin G; Osman H; Crary J; Lu M; Cheng L; Palasis M; Wilensky RL
    Eur Heart J; 2006 May; 27(9):1114-22. PubMed ID: 16510464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning].
    Liu LH; Sun QY; Hu KX; Huang YJ; Fan CB; Sun Z; Yao B; Guo M; Zhao CH; Ai HS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):385-8. PubMed ID: 16251015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
    Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
    J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.